The equilibrium and kinetic drug binding properties of the mouse P-gp1a and P-gp1b P-glycoproteins are similar

British Journal of Cancer

Volumn 81, Issue 5, 1999, Pages 783-789

  Taylor, J C ^a   Ferry, D R ^b   Higgins, C F ^c   Callaghan, R ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Drug binding; MDR; P glycoprotein; Steroid hormones

Indexed keywords

GLYCOPROTEIN P; ISOPROTEIN; NICARDIPINE; PROGESTERONE; STEROID; TRITIUM; VERAPAMIL; VINBLASTINE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING KINETICS; DRUG PROTEIN BINDING; HORMONE TRANSPORT; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; TISSUE DISTRIBUTION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BINDING, COMPETITIVE; CELL MEMBRANE; CHO CELLS; CRICETINAE; DRUG RESISTANCE, MULTIPLE; ISOQUINOLINES; KINETICS; MICE; NICARDIPINE; P-GLYCOPROTEINS; PROGESTERONE; PROTEIN BINDING; PROTEIN ISOFORMS; QUINAZOLINES; VERAPAMIL; VINBLASTINE;

EID: 0032718620     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690764     Document Type: Article

References (33)

1. Altuvia S, Stein WD, Goldenberg S, Kane SE, Pastan I and Gottesman MM (1993) Targeted disruption of the mouse mdr1b gene reveals that steroid hormones enhance mdr pene expression. J Biol Chem 268: 27127-27132
2. Arceci RJ, Croop JM, Horwitz SB and Housman D (1988) The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc Natl Acad Sci USA 85: 4350-4354
3. Ayesh S, Shao Y-M and Stein WD (1996) Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein. Biochim Biophys Acta 1316: 8-18
4. Barnes KM, Dickstein B, Cutler GB, Fojo T and Bales SE (1996) Steroid transport, accumulation and antagonism of P-glycoprotein in multidrug resistant cells. Biochemistry 35: 4820-4827
5. Burgisser E (1984) Radioligand receptor binding studies; what's wrong with the Scatchard analysis? Trends Biochem Sci 142-144
6. 50) of an enzymic reaction. Biochem Pharmacol 22: 3099-3108
7. Croop JM, Raymond M, Haber D, Devault A, Arceci RJ, Gross P and Housman DE (1989) The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol Cell Biol 9: 1346-1350
8. De Lean A, Munson PJ and Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: applications to bioassay, radioligand assay and physiological dose response curves. J Physiol 235: E97-E102
9. Devault A and Gros P (1990) Two members of the mouse mdr gere family confer multidrug resistance with overlapping but distinct drug specificities. Mol Cell Biol 10: 1652-1663
10. Ferry DR, Russell MA and Cullen MH (1992) P glycoprotein possesses a 1,4-dihydropyridine selective drug acceptor site which is allosterically coupled to a vinca alkaloid selective binding site. Biochem Biophys Res Commun 18: 440-445
11. Ferry DR, Malkhandi JP, Russell MA and Kerr DJ (1995) Allosteric regulation of [3H]vinblastine binding to P-glycoprotein of MCF-7 Adr cells by dexniguldipine. Biochem Pharmacol 49: 1851-1861
12. Garrigos M, Mir LM and Orlowski S (1997) Competitive and non-competitive inhibition of the multidrug resistance associated p glycoprotein atpase: further experimental evidence for a multisite model. Eur J Biochem 244: 644-673
13. Georges E, Bradley G, Gariepy J and Ling V (1990) Detection of P-glycoprotein isoforms by gene specific monoclonal antibodies. Proc Natl Acad Sci USA 87: 152-156
14. Gill DR, Hyde SC, Higgins CF, Valverde MA, Mintenig, GM and Sepulveda FV (1992) Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein. Cell 71: 23-32
15. Gottesman MM and Pastan I (1988) The multi-drug transporter: a double edged sword. J Biol Chem 263: 12163-12166
16. Gros P, Croop J and Housman D (1986) Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47: 371-380
17. Hardy SP, Goodfellow HR, Valverde MA, Gill DR, Sepulveda FV and Higgins CF (1995) Protein kinase C-mediated phosphorylation of the human multidrug resistance P-glycoprotein regulates cell volume-activated chloride channels. EMBO J 14: 68-75
18. Kajiji S, Talbot F, Grizzuti K, Van Dyke-Phillips V, Agresti M, Safa A and Gros P (1993) Functional analysis of P glycoprotein mutants identifies predicted transmembrane domain 11 as a putative drug binding site. Biochemistry 32: 4185-4194
19. 919/941. Biochemistry 33: 5041-5048
20. Kenakin T (1997) In Pharmacologic Analysis of Drug-Receptor Interaction pp. 198-241. Lippincott-Raven, Philadelphia
21. + gradient stimulated uptake. J Biol Chem 252: 1990-1997
22. Malkhandi J, Ferry DR, Boer R, Gekeler V, Ise W and Kerr DJ (1994) Dexniguldipine-HCl is a potent allosteric inhibitor ['H]vinblastinc binding to P-glycoprotein of CCRF ADR5000 cells. Eur J Pharmacol 288: 105-114
23. Martin C, Berridge G, Higgins CF and Callaghan R (1997) The multidrug resistance reversal agent SR33557 and modulation of vinca alkaloid binding to P-glycoprotein by an allosteric interaction. British J Pharmacol 121: in press
24. Orlowski S, Mir LM, Belehradek JR and Garrigos M (1996) Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators. Biochem J 317: 515-522
25. Piekarz RL, Cohen D and Horwitz SB (1993) Progesterone regulates the murine multidrug resistance mdr1b gene. J Biol Chem 268: 7613-7616
26. Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CAAM, van der Valk MA, Robanus-Maandag EC, te Riele HPJ, Berns JM and Borst P (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood - brain barrier and 10 increased sensitivity to drugs. Cell 77: 491-502
27. Spoelstra EC, Westerhoff HV, Dekker H and Lankelma J (1992) Kinetics of doxorubicin transport by P-glycoprotein of intact cancer cells. Eur J Biochem 207: 567-579
28. Tang-Wai DF, Kajiji S, DiCapua F, de Graaf D, Roninson IB and Gros P (1995) Human (MDR1) and mouse (mdrl, mdr3) P glycoproteins can be distinguished by their respective drug resistance profiles and sensitivity to modulators. Biochemistry 34: 32-39
29. Towbin H, Staehlin T and Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354
30. Trezise AEO, Romano PR, Gill DR, Hyde SC, Sepulveda FV, Buchwald M and Higgins CF (1992) The multidrug resistance and cystic-fibrosis genes have complimentary patterns of epithelial expression. EMBO J 11: 4291-4303
31. Ueda K, Okamura N, Hirai M, Tanigawara Y, Sacki T, Kioka N, Komano T and Hori R (1992) Human P-glycoprotein transports cortisol, aldosterone, but not progesterone. J Biol Chem 267: 24248-24252
32. Valverde MA, Bond TD, Hardy SP, Taylor JC, Higgins CF, Altamirano J and Alvarez-Leefmans FJ (1996) The multidrug resistance P-glycoprotein modulates cell regulatory volume decrease. EMBO J 15: 4460-4468
33. Yang CP, Cohen D, Greenberger LM, Hsu SI and Horwitz SB (1990) Differential transport properties of two mdr gene products are distinguished by progesterone. J Biol Chem 265: 10282-10288